Week in review: Retinoblastoma survival rates, generic of Restasis approved, prematurity leads to long-term vision problems

This week, global retinoblastoma survival disparities remain despite progress. the first generic for Restasis is approved in the US, and ophthalmic problems due to prematurity persist into adulthood.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553